Results 161 to 170 of about 13,043 (220)

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial.

J Indian Assoc Pediatr Surg
Singh S, Srivastava NK, Upadhyaya A, Kumar M, Pawar N, Kapoor R.   +5 more
europepmc   +1 more source

Integrating contrast sensitivity and vascular resistance into a nomogram to predict postoperative treatment outcomes in primary glaucoma. [PDF]

Eur J Med Res
Liu R, Guo H, Gao T, Huo Q, Shao M.
europepmc   +1 more source

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial. [PDF]

J Clin Med
Kim M, Lee CK, Shin J, Kim D, Rho S.
europepmc   +1 more source

First-order derivative spectrophotometric method for simultaneous determination of brinzolamide and timolol maleate in ophthalmic formulation

Srushti Tambe, Sabya Sachi Das, Kiran Shahane, Sandeep Kumar Singh, Janne Ruokolainen, Purnima D. Amin, Kavindra Kumar Kesari   +6 more
openalex   +1 more source

Central Contrast Sensitivity as an Outcome Measure in Randomized Controlled Trials in Glaucoma-A Systematic Review. [PDF]

Life (Basel)
Sverstad A, Møller JR, Virgili G, Azuara-Blanco A, Freiberg J, Ahrensberg S, Kristianslund O, Petrovski G, Kolko M.   +8 more
europepmc   +1 more source

Colloid-Forming Prodrug-Hydrogel Composite Prolongs Lower Intraocular Pressure in Rodent Eyes after Subconjunctival Injection. [PDF]

Adv Mater
Dang M, Slaughter KV, Cui H, Jiang C, Zhou L, Matthew DJ, Sivak JM, Shoichet MS.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Travoprost/Timolol

Drugs & Aging, 2006
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Sheridan M, Hoy, Susan J, Keam, Gillian M, Keating   +2 more
openaire   +2 more sources

Timolol

2007
Timolol is a non-selective, beta adrenoceptor antagonist at beta-1 and beta-2 adrenoceptors. It lacks the partial agonist and local anesthetic properties that some drugs in this class have. It is most commonly used to treat glaucoma and cardiovascular diseases. Timolol is moderately lipophilic. Absorption of timolol after topical application to the eye
openaire   +2 more sources